Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1964 1
1965 2
1968 1
1969 1
1970 3
1971 1
1973 2
1974 2
1975 1
1976 1
1978 1
1979 3
1980 7
1981 3
1982 2
1983 9
1984 2
1985 4
1986 3
1987 10
1988 5
1989 4
1990 8
1991 7
1992 8
1993 9
1994 15
1995 12
1996 12
1997 13
1998 10
1999 5
2000 21
2001 17
2002 17
2003 19
2004 23
2005 29
2006 33
2007 25
2008 30
2009 22
2010 36
2011 43
2012 49
2013 60
2014 78
2015 88
2016 68
2017 101
2018 75
2019 65
2020 73
2021 83
2022 88
2023 98
2024 104
2025 63

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,400 results

Results by year

Filters applied: . Clear all
Page 1
Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population.
Casadei-Gardini A, Rimini M, Tada T, Suda G, Shimose S, Kudo M, Cheon J, Finkelmeier F, Lim HY, Rimassa L, Presa J, Masi G, Yoo C, Lonardi S, Tovoli F, Kumada T, Sakamoto N, Iwamoto H, Aoki T, Chon HJ, Himmelsbach V, Pressiani T, Montes M, Vivaldi C, Soldà C, Piscaglia F, Hiraoka A, Sho T, Niizeki T, Nishida N, Steup C, Iavarone M, Di Costanzo G, Marra F, Scartozzi M, Tamburini E, Cabibbo G, Foschi FG, Silletta M, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Ochi H, Yasuda S, Toyoda H, Ogawa C, Nishimura T, Hatanaka T, Kakizaki S, Shimada N, Kawata K, Tada F, Ohama H, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Imai M, Kosaka H, Naganuma A, Koizumi Y, Nakamura S, Kaibori M, Iijima H, Hiasa Y, Burgio V, Persano M, Della Corte A, Ratti F, De Cobelli F, Aldrighetti L, Cascinu S, Cucchetti A. Casadei-Gardini A, et al. Among authors: nishida n. Eur J Cancer. 2023 Feb;180:9-20. doi: 10.1016/j.ejca.2022.11.017. Epub 2022 Nov 25. Eur J Cancer. 2023. PMID: 36527976 Clinical Trial.
Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in hepatocellular carcinoma patients.
Persano M, Rimini M, Tada T, Suda G, Shimose S, Kudo M, Cheon J, Finkelmeier F, Lim HY, Presa J, Masi G, Yoo C, Lonardi S, Tovoli F, Kumada T, Sakamoto N, Iwamoto H, Aoki T, Chon HJ, Himmelsbach V, Niizeki T, Montes M, Vivaldi C, Soldà C, Stefanini B, Hiraoka A, Sho T, Nishida N, Steup C, Iavarone M, Di Costanzo G, Marra F, Tamburini E, Cabibbo G, Foschi FG, Silletta M, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Ochi H, Yasuda S, Toyoda H, Ogawa C, Nishimura T, Hatanaka T, Kakizaki S, Shimada N, Kawata K, Tada F, Ohama H, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Imai M, Kosaka H, Naganuma A, Koizumi Y, Nakamura S, Kaibori M, Iijima H, Hiasa Y, Campani C, Amadeo E, Rossari F, Burgio V, Cascinu S, Scartozzi M, Casadei-Gardini A. Persano M, et al. Among authors: nishida n. Eur J Cancer. 2023 Aug;189:112933. doi: 10.1016/j.ejca.2023.05.021. Epub 2023 Jun 1. Eur J Cancer. 2023. PMID: 37385069 Free article.
Proposal of discontinuation criteria of atezolizumab plus bevacizumab after curative conversion therapy for unresectable early-to-intermediate-stage hepatocellular carcinoma: a multicenter proof-of-concept study.
Aoki T, Kudo M, Nishida N, Ueshima K, Tsuchiya K, Tada T, Morita M, Chishina H, Takita M, Hagiwara S, Ida H, Minami Y, Kuroda H, Nakamura N, Hiraoka A, Tomonari T, Tani J, Naganuma A, Kakizaki S, Ogawa C, Hatanaka T, Ishikawa T, Kawata K, Takebe A, Matsumoto I, Hidaka M, Kurosaki M, Kumada T, Izumi N. Aoki T, et al. Among authors: nishida n. J Gastroenterol. 2025 Jun;60(6):738-753. doi: 10.1007/s00535-025-02233-z. Epub 2025 Mar 7. J Gastroenterol. 2025. PMID: 40055288 Free PMC article.
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis.
Asselta R, Paraboschi EM, Gerussi A, Cordell HJ, Mells GF, Sandford RN, Jones DE, Nakamura M, Ueno K, Hitomi Y, Kawashima M, Nishida N, Tokunaga K, Nagasaki M, Tanaka A, Tang R, Li Z, Shi Y, Liu X, Xiong M, Hirschfield G, Siminovitch KA; Canadian-US PBC Consortium; Italian PBC Genetics Study Group; UK-PBC Consortium; Japan PBC-GWAS Consortium; Carbone M, Cardamone G, Duga S, Gershwin ME, Seldin MF, Invernizzi P. Asselta R, et al. Among authors: nishida n. Gastroenterology. 2021 Jun;160(7):2483-2495.e26. doi: 10.1053/j.gastro.2021.02.061. Epub 2021 Mar 4. Gastroenterology. 2021. PMID: 33675743 Free PMC article.
Prion infection impairs the cellular response to oxidative stress.
Milhavet O, McMahon HE, Rachidi W, Nishida N, Katamine S, Mangé A, Arlotto M, Casanova D, Riondel J, Favier A, Lehmann S. Milhavet O, et al. Among authors: nishida n. Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13937-42. doi: 10.1073/pnas.250289197. Proc Natl Acad Sci U S A. 2000. PMID: 11095725 Free PMC article.
Molecular classification of hepatocellular carcinoma based on zoned metabolic feature and oncogenic signaling pathway.
Aoki T, Nishida N, Kurebayashi Y, Sakai K, Fujiwara N, Tsurusaki M, Hanaoka K, Morita M, Chishina H, Takita M, Hagiwara S, Ida H, Ueshima K, Minami Y, Takebe A, Murase T, Kamei K, Nakai T, Matsumoto I, Nishio K, Kudo M. Aoki T, et al. Among authors: nishida n. Clin Mol Hepatol. 2025 Jul;31(3):981-1002. doi: 10.3350/cmh.2024.1088. Epub 2025 Mar 11. Clin Mol Hepatol. 2025. PMID: 40065709 Free PMC article.
β cell dedifferentiation, the underlying mechanism of diabetes in Wolfram syndrome.
Amo-Shiinoki K, Tanabe K, Nishimura W, Hatanaka M, Kondo M, Kagawa S, Zou M, Morikawa S, Sato Y, Komatsu M, Mizukami H, Nishida N, Asahara SI, Masutani H, Tanizawa Y. Amo-Shiinoki K, et al. Among authors: nishida n. Sci Transl Med. 2025 Feb 19;17(786):eadp2332. doi: 10.1126/scitranslmed.adp2332. Epub 2025 Feb 19. Sci Transl Med. 2025. PMID: 39970233
Second-line treatment patterns and outcomes in advanced HCC after progression on atezolizumab/bevacizumab.
Wu M, Fulgenzi CAM, D'Alessio A, Cortellini A, Celsa C, Manfredi GF, Stefanini B, Wu YL, Huang YH, Saeed A, Pirozzi A, Pressiani T, Rimassa L, Schoenlein M, Schulze K, von Felden J, Mohamed Y, Kaseb AO, Vogel A, Roehlen N, Silletta M, Nishida N, Kudo M, Vivaldi C, Balcar L, Scheiner B, Pinter M, Singal AG, Glover J, Ulahannan S, Foerster F, Weinmann A, Galle PR, Parikh ND, Hsu WF, Parisi A, Chon HJ, Pinato DJ, Ang C. Wu M, et al. Among authors: nishida n. JHEP Rep. 2024 Oct 10;7(2):101232. doi: 10.1016/j.jhepr.2024.101232. eCollection 2025 Feb. JHEP Rep. 2024. PMID: 39877031 Free PMC article.
Effects of sclerostin antibody on bone healing.
Mihara A, Yukata K, Seki T, Iwanaga R, Nishida N, Fujii K, Nagao Y, Sakai T. Mihara A, et al. Among authors: nishida n. World J Orthop. 2021 Sep 18;12(9):651-659. doi: 10.5312/wjo.v12.i9.651. eCollection 2021 Sep 18. World J Orthop. 2021. PMID: 34631449 Free PMC article. Review.
Cross-saturation and transferred cross-saturation experiments.
Ueda T, Takeuchi K, Nishida N, Stampoulis P, Kofuku Y, Osawa M, Shimada I. Ueda T, et al. Among authors: nishida n. Q Rev Biophys. 2014 May;47(2):143-87. doi: 10.1017/S0033583514000043. Epub 2014 Apr 29. Q Rev Biophys. 2014. PMID: 24780282 Review.
1,400 results